David Pernock
2015 - Fibrocell Science
In 2015, David Pernock earned a total compensation of $1.2M as Former Chairman of the Board and Chief Executive Officer at Fibrocell Science, a 150% increase compared to previous year.
Compensation breakdown
| Option Awards | $736,595 |
|---|---|
| Salary | $490,000 |
| Total | $1,226,595 |
Pernock received $736.6K in option awards, accounting for 60% of the total pay in 2015.
Pernock also received $490K in salary.
Rankings
In 2015, David Pernock's compensation ranked 6,954th out of 13,638 executives tracked by ExecPay. In other words, Pernock earned more than 49.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,954 out of 13,638 | 49th |
Division Manufacturing | 2,633 out of 5,190 | 49th |
Major group Chemicals And Allied Products | 945 out of 1,854 | 49th |
Industry group Drugs | 759 out of 1,528 | 50th |
Industry Pharmaceutical Preparations | 589 out of 1,182 | 50th |
Source: SEC filing on April 27, 2017.
Pernock's colleagues
We found five more compensation records of executives who worked with David Pernock at Fibrocell Science in 2015.
2015
Keith Goldan
Fibrocell Science
Chief Financial Officer
2015
Michael Marino
Fibrocell Science
General Counsel
2015
John Maslowski
Fibrocell Science
Chief Executive Officer
2015
Kimberly Smith
Fibrocell Science
Chief Financial Officer
2015
Robert Sheroff
Fibrocell Science
Former Vice President, Technical Operations
News
Eagle Pharmaceuticals CEO Scott Tarriff's 2021 pay falls 32% to $6.5M
June 15, 2022
Eagle Pharmaceuticals CEO Scott Tarriff's 2020 pay rises 20% to $9.5M
April 30, 2021
Eagle Pharmaceuticals CEO Scott Tarriff's 2019 pay falls 30% to $7.9M
April 29, 2020
Eagle Pharmaceuticals CEO Scott Tarriff's 2018 pay jumps 41% to $11M
April 30, 2019